XML 93 R73.htm IDEA: XBRL DOCUMENT v3.23.1
Share-Based Compensation - Additional Information (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Nov. 12, 2021
USD ($)
tranche
trading_day
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
participant
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
shares
Nov. 06, 2020
shares
Jan. 02, 2019
shares
Share-based Compensation Arrangement by Share-based Payment Award                
Accelerated vesting 3,724              
Total fair value of common shares vested | $   $ 281   $ 2,198        
Legacy TOI Earnout Shares                
Share-based Compensation Arrangement by Share-based Payment Award                
Contingent consideration, liability (in shares) 12,500,000              
Number of tranches | tranche 2              
Earnout measurement period 2 years              
Initial stock price threshold | $ / shares $ 15.00              
Earnout period 3 years              
Threshold trading days | trading_day 20              
Threshold trading day period | trading_day 30              
Legacy TOI Earnout Shares | Derivative Instrument, Period, One                
Share-based Compensation Arrangement by Share-based Payment Award                
Contingent consideration, liability (in shares) 5,000,000              
Stock price trigger (in dollars per share) | $ / shares $ 12.50              
Legacy TOI Earnout Shares | Derivative Instrument, Period, Two                
Share-based Compensation Arrangement by Share-based Payment Award                
Contingent consideration, liability (in shares) 7,500,000              
DFPH Earnout Shares                
Share-based Compensation Arrangement by Share-based Payment Award                
Contingent consideration, liability (in shares) 575,000              
Number of tranches | tranche 2              
Earnout period 3 years              
Escrow deposit percentage 50.00%              
Stock options                
Share-based Compensation Arrangement by Share-based Payment Award                
Term of award   10 years            
Maximum total number of common shares for which Stock options may be granted (in shares)             15,640 13,640
Number of shares outstanding (in shares) 11,850 9,832,667 8,049,474 8,115,141 8,049,474 6,921,180    
Share options exchanged (in shares) 6,925,219              
Compensation costs recognized | $   $ 2,707   $ 3,255        
Cash used to settle award | $ $ 20,597              
Accelerated cost | $ $ 19,953              
Unrecognized compensation cost | $   $ 20,080            
Unrecognized compensation cost expected to be recognized over a weighted average period   2 years 11 months 1 day            
Stock options | First anniversary of grant date                
Share-based Compensation Arrangement by Share-based Payment Award                
Percentage of stock options   25.00%            
Stock options | Equal monthly-basis vesting through fourth anniversary of grant date                
Share-based Compensation Arrangement by Share-based Payment Award                
Percentage of stock options   75.00%            
Stock options | 2021 Plan                
Share-based Compensation Arrangement by Share-based Payment Award                
Maximum total number of common shares for which Stock options may be granted (in shares)   5,283,068            
RSUs                
Share-based Compensation Arrangement by Share-based Payment Award                
Share options exchanged (in shares) 1,291,492              
Compensation costs recognized | $   $ 2,088   $ 1,491        
Unrecognized compensation cost expected to be recognized over a weighted average period   2 years 8 months 26 days            
Weighted-average grant date fair value (in dollars per share) | $ / shares   $ 0.48   $ 7.09        
Unrecognized compensation expense | $   $ 14,435            
Vested in period (in shares)   331,675            
Net settled to cover the required withholding tax upon vesting   0            
RSUs | First anniversary of grant date                
Share-based Compensation Arrangement by Share-based Payment Award                
Percentage of stock options   16.67%            
RSUs | Equal monthly-basis vesting through fourth anniversary of grant date                
Share-based Compensation Arrangement by Share-based Payment Award                
Percentage of stock options   83.33%            
Restricted Stock Awards                
Share-based Compensation Arrangement by Share-based Payment Award                
Number of shares outstanding (in shares) 2,210              
Employees Earnout Shares                
Share-based Compensation Arrangement by Share-based Payment Award                
Compensation costs recognized | $   $ 112   $ 3,807        
Unrecognized compensation cost expected to be recognized over a weighted average period   6 months 3 days            
Number of shares outstanding (in shares)   1,401,064 1,417,632 1,560,857 1,417,632 1,602,435    
Unrecognized compensation expense | $   $ 391            
Vested in period (in shares)   0   41,578        
Employees Earnout Shares | First anniversary of grant date                
Share-based Compensation Arrangement by Share-based Payment Award                
Weighted average grant date fair value (in dollars per share) | $ / shares $ 8.35              
Employees Earnout Shares | Equal monthly-basis vesting through fourth anniversary of grant date                
Share-based Compensation Arrangement by Share-based Payment Award                
Weighted average grant date fair value (in dollars per share) | $ / shares $ 6.76              
Medical RSUs                
Share-based Compensation Arrangement by Share-based Payment Award                
Compensation costs recognized | $   $ 58            
Number of shares outstanding (in shares)   0 147,470 0 147,470 0    
Vested in period (in shares)   155,787   0        
Award requisite service period         1 year      
Shares granted, trailing closing price per share preceding grant date, period   5 days            
Number of participants | participant     21          
Medical RSUs, incremental share-based compensation expense | $     $ 187          
Medical RSUs, after forfeitures share-based compensation expense | $     (11)          
Fair value of the liability-classified medical RSU outstanding | $     $ 264   $ 264      
Equity-classified medical RSUs, weighted-average grant-date fair value (in dollars per share) | $ / shares         $ 3.56      
Equity-classified awards outstanding (in shares)   0   0